ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,597,006 | +40.9% | 316,555 | +61.9% | 0.13% | +38.0% |
| Q2 2023 | $4,682,153 | +115.0% | 195,497 | +69.0% | 0.09% | +109.1% |
| Q1 2023 | $2,177,455 | +94.2% | 115,699 | +45.4% | 0.04% | -12.0% |
| Q2 2022 | $1,121,000 | +124.6% | 79,579 | +272.5% | 0.05% | +78.6% |
| Q4 2021 | $499,000 | -35.4% | 21,366 | -28.7% | 0.03% | -75.2% |
| Q1 2021 | $773,000 | +257.9% | 29,975 | +643.1% | 0.11% | +222.9% |
| Q4 2020 | $216,000 | -71.4% | 4,034 | -77.9% | 0.04% | -78.5% |
| Q3 2020 | $754,000 | – | 18,287 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |